Company / Shareholders' Equity
OMEROS CORP Shareholders' Equity History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$182.6M
FY2024
5-year range
-$182.6M / $85.7M
FY2020-FY2024
Trend
-630.9%
vs FY2023
Sector context
#203 of 213
Health Care
What the data says
OMEROS CORP reports negative total equity of -$183M in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$183M in FY2024.
Declined from $86M to -$183M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 213This company -$182.6M Sector average $2.5B
▼
-107.2% below sector average
Key checks
Key Insights
- In FY2024, shareholders' equity decreased 630.9% year-over-year.
- Ranks #203 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$182.6M | -630.9% |
| FY2023 | -$25.0M | -129.2% |
| FY2022 | $85.7M | +260.3% |
| FY2021 | $23.8M | +119.7% |
| FY2020 | -$120.8M | -10.8% |
| FY2019 | -$109.0M | -8.9% |
| FY2018 | -$100.2M | -3459.2% |
| FY2017 | -$2.8M | +92.5% |
| FY2016 | -$37.4M | -103.7% |
| FY2015 | -$18.4M | +56.9% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026